Celebrity News

Menopausal Relief Options – It’s About Time!

If you are one of the 60%-80% of women worldwide who suffer from vasomotor symptoms (aka hot flashes and night sweats), A new drug may be available to you in the near future, It’s called a phazolintent, and it’s especially notable because it’s non-hormonal. While we know that hormonal replacement therapy has been shown to be safe and effective for many women, we also know that not everyone is a suitable candidate, whether because of medical history or because of their own preferences.

The makers of Fezolinetant recently announced that the FDA has approved their application, so we have some time before we get word of approval. While we won’t know for the time being if this is something women can safely rely on, the news is encouraging.

Women’s health concerns and women themselves have been kept out of clinical trials for too long. We know there is a significant gender gap in research, and it shows. We need more randomized controlled trials (considered the gold standard) that focus on women’s health issues, diagnosis and treatment. Menopause is a particularly simplistic and overlooked condition., and women who are forced to compromise their quality of life because of acute symptoms have few options for resolution. So when I hear an announcement indicating progress on our part, I sit down and take notice.

The safety and efficacy of fezolinetant remain to be seen, but you can bet I’m watching. it will happen without you saying I am expecting a positive result from this medicine, But I also expect a ripple effect in the pharmaceutical industry. Now is the time to address the demands of women who need better and more options for our healthcare. To learn more, take our Menopause Quiz here!

For more information about menopause or your sexual health, contact us for a free phone consultation!

** By submitting your information, you agree to receive emails from Maze from time to time; You can opt out at any time. Maze does not share email addresses nor any other personal or medical data with third parties.